Renal Carcinoma Flashcards
What are renal tumours?
Renal tumours are characterised by a presentation of haematuria, flank pain and a flank mass.
What is the histology of renal tumours?
Histologically, primary renal tumours are most commonly caused by a clear cell adenocarcinoma originating from the epithelial cells of the PCT in the parenchyma, which has both solid and liquid components and are septated.
What are the features of paraneoplastic syndrome?
Excess EPO production and angiogenesis and polycythaemia however this results in anaemia of chronic disease, which initially begins as normocytic and progresses onto microcytic anaemia as iron stores are used up. Excess PTH production results in hypercalcaemia and excess ACTH causing Cushing’ disease
What is the common metastases in renal carcinoma,a?
Secondary Metastasis can occur, causing:
-> the left renal vein to the gonads and result in left-sided varicocele (enlarged vein.)
-> cannonball lesion on the lungs
-> Lytic lesions on the bones
-> Painless lymphadenopathy
-> vascularised haemorrhagic nodules on the skin
What are the risk factors for renal cell carcinoma?
Risk factors for renal cell carcinoma is smoking, obesity, old age, male and exposure to lead, asbestos and petroleum products, dialysis, radiotherapy and chemotherapy.
What is the diagnosis of renal cell carcinoma?
Diagnosis of renal cell cancer is made through CT scan of the abdomen, ultrasound or MRI. A CT-TAP may be used, where it images the thorax, abdomen and pelvis when there is undiagnosed weight loss.
What is Von Hippel Laundau syndrome?
Von Hippel Laundau syndrome is a genetic disorder which increases the risk for renal carcinoma, where there are tumours called haemangioblasts formed of new blood vessels, associated with cyst formation in the kidneys. This also increases the risk of phaemochromocytoma.
What are the types of renal cell carcinoma?
Clear cell
Papillary
Chromophobe
What is clear cell carcinoma?
Clear cell carcinomas which make up majority of cases, where there are sporadic, unilateral tumours that are mitochondria rich and tumour cells are rounded and clear due to hig presence of glycogen and lipids.
What is papillary carcinoma?
Papillary carcinoma, which arises from the renal tubules and presents with finger-like growths and projections. Type 1 PC grows slower and has less spread compared to Type 2 PC.
What is type 1 papillary carcinoma?
Type 1 is associated with hereditary papillary carcinoma
What is type 2 carcinomas?
Type 2 is associated with hereditary leiomyatosis and aggressive papillary carcinoma syndrome.
What is the most common renal cell carcinoma in children?
Wilm’s tumour which is the most common type of kidney cancer in under 15’s and more common in girls, associated with a genetic mutation of WT1 gene, important for the development of the kidneys and the gonads.
This is followed by renal cell carcinoma and congenital mesoblastid nephroma.
What is congenital mesoblastic nephroma?
Congenital mesoblastic nephroma occurs within the first 3 months of life and is a unilateral cancer of the renal mesenchyme, which manifests with a abdominal mass most commonly, and in lesser cases, polyhydroamniosis, haematuria and hypertension.
What are the common sites of metastasis in renal cancers?
Renal cancers commonly metastasise to the lungs, lymph nodes, bone and the liver. They frequently tend to have paraneoplastic syndrome, with anaemia, hypercalcaemia and Stauufer syndrome.
-> Hypercalcaemia indicates bony metastasis due to osteolytic effects of excess ACTH and may lead to bone compression.
What is Stauffer syndrome?
Stauffer syndrome is where elevation of liver enzymes which indicate impaired bile flow in the abscence of obstruction.
What is the treatment of renal cell carcinoma?
Treatment of renal cell carcinoma is based on staging via the TNM system:
* surgical resectioning, especially in the earlier stages because chemotherapy and radiotherapy are generally ineffective
* Combination of nephroctemy and biological therapies are more ideal for late stage renal cancer involving metastasis such as IL-2 inhibitors, interferon-alpha inhibitors and tyrosine kinase inhibitors.